Subscribe To
Continued strong cresemba® (isavuconazole) sales by astellas in the u.s. trigger chf 20 million sales milestone payment to basilea
Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meetin...
January 9, 2023, 6:29 am
Astrazeneca to buy u.s.-based cincor pharma in $1.8 bln deal
AstraZeneca said on Monday it will buy U.S.-based clinical-stage biopharmaceutical firm CinCor Pharma I...
January 9, 2023, 2:16 am
Phathom pharmaceuticals announces positive topline results from phase 3 phalcon-nerd-301 trial evaluating daily dosing of vonoprazan for symptomatic non-erosive gastroesophageal reflux disease (nerd)
Both vonoprazan 10 mg and 20 mg doses met the primary endpoint and showed highly statistically significant greater percentage of 24-hour heartburn fre...
January 8, 2023, 11:00 pm
Eigr important deadline tomorrow: rosen, global investor counsel, encourages eiger biopharmaceuticals, inc. investors to secure counsel before important january 9 deadline in securities class action –
NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger Bio...
January 8, 2023, 6:47 pm
Eigr important deadline tomorrow: rosen, global investor counsel, encourages eiger biopharmaceuticals, inc. investors to secure counsel before important january 9 deadline in securities class action –
NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger Bio...
January 8, 2023, 6:47 pm
Eigr important deadline tomorrow: rosen, global investor counsel, encourages eiger biopharmaceuticals, inc. investors to secure counsel before important january 9 deadline in securities class action –
NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger Bio...
January 8, 2023, 6:47 pm
Eigr important deadline tomorrow: rosen, global investor counsel, encourages eiger biopharmaceuticals, inc. investors to secure counsel before important january 9 deadline in securities class action –
NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger Bio...
January 8, 2023, 6:47 pm
Eigr important deadline tomorrow: rosen, global investor counsel, encourages eiger biopharmaceuticals, inc. investors to secure counsel before important january 9 deadline in securities class action –
NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger Bio...
January 8, 2023, 6:47 pm
Eigr important deadline tomorrow: rosen, global investor counsel, encourages eiger biopharmaceuticals, inc. investors to secure counsel before important january 9 deadline in securities class action –
NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger Bio...
January 8, 2023, 6:47 pm
Eigr important deadline tomorrow: rosen, global investor counsel, encourages eiger biopharmaceuticals, inc. investors to secure counsel before important january 9 deadline in securities class action –
NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger Bio...
January 8, 2023, 6:47 pm
Cymabay therapeutics announces collaboration with kaken pharmaceutical co., ltd. to develop and commercialize seladelpar in japan for primary biliary cholangitis
Advances strategy to partner seladelpar for PBC outside U.S. Brings in approximately $34.0 million upfront payment Japan represents an important marke...
January 8, 2023, 5:00 pm
Shareholder investigation: halper sadeh llc investigates opnt, cbio
NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...
January 8, 2023, 1:47 pm
Assertio holdings, inc. reports inducement grants under nasdaq listing rule 5635(c)(4)
LAKE FOREST, Ill, Jan. 06, 2023 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty ...
January 6, 2023, 9:30 pm
5 top pharma stocks of 2022 to buy for the long haul
Not every stock went down in 2022. Shares in some the biggest pharmaceutical companies rose in price....
January 6, 2023, 6:26 pm
Why shares of aurinia pharmaceuticals soared this week
A patent settlement and improved financials sent the stock soaring....
January 6, 2023, 4:49 pm
Four undervalued healthcare stocks for 2023
These four health care stocks could be undervalued: Pfizer Inc., Regeneron pharmaceuticals Inc., Innovi...
January 6, 2023, 11:21 am
Is novo nordisk (nvo) stock outpacing its medical peers this year?
Here is how Novo Nordisk (NVO) and Acumen pharmaceuticals, Inc. (ABOS) have performed compared to their...
January 6, 2023, 11:17 am
Atai life sciences shares plummet as r-ketamine candidate fails to meet primary endpoint in phase 2a trial
atai Life Sciences (NASDAQ:ATAI) shares tumbled more than 40% in pre-market trading on Friday after the company reported disappointing results from it...
January 6, 2023, 9:46 am
Fate therapeutics stocks heads for record selloff after janssen collaboration terminated and job cuts
Shares of Fate Therapeutics Inc. FATE, -1.08% plunged 56.8% in premarket trading, putting them on track for a record one-day selloff, after the bio
January 6, 2023, 8:49 am
Casi pharmaceuticals to run clinical trial for multiple myeloma drug in china
Shares of Casi pharmaceuticals Inc. CASI, +3.63% were up 10% in premarket trading on Friday after the c...
January 6, 2023, 8:42 am